WO2007148293A2 - Composition pour soins personnels - Google Patents

Composition pour soins personnels Download PDF

Info

Publication number
WO2007148293A2
WO2007148293A2 PCT/IB2007/052377 IB2007052377W WO2007148293A2 WO 2007148293 A2 WO2007148293 A2 WO 2007148293A2 IB 2007052377 W IB2007052377 W IB 2007052377W WO 2007148293 A2 WO2007148293 A2 WO 2007148293A2
Authority
WO
WIPO (PCT)
Prior art keywords
composition
skin
sunscreen
mixtures
keratinous tissue
Prior art date
Application number
PCT/IB2007/052377
Other languages
English (en)
Other versions
WO2007148293A3 (fr
Inventor
Paul Robert Tanner
Original Assignee
The Procter & Gamble Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by The Procter & Gamble Company filed Critical The Procter & Gamble Company
Priority to CA002654291A priority Critical patent/CA2654291A1/fr
Priority to MX2009000126A priority patent/MX2009000126A/es
Priority to EP07789751A priority patent/EP2029238A2/fr
Publication of WO2007148293A2 publication Critical patent/WO2007148293A2/fr
Publication of WO2007148293A3 publication Critical patent/WO2007148293A3/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/31—Hydrocarbons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/35—Ketones, e.g. benzophenone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/37—Esters of carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4906—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
    • A61K8/4913—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having five membered rings, e.g. pyrrolidone carboxylic acid
    • A61K8/492—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having five membered rings, e.g. pyrrolidone carboxylic acid having condensed rings, e.g. indol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
    • A61K8/4966—Triazines or their condensed derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/58—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing atoms other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur or phosphorus
    • A61K8/585—Organosilicon compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
    • A61K8/89—Polysiloxanes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
    • A61K8/89—Polysiloxanes
    • A61K8/891—Polysiloxanes saturated, e.g. dimethicone, phenyl trimethicone, C24-C28 methicone or stearyl dimethicone
    • A61K8/894—Polysiloxanes saturated, e.g. dimethicone, phenyl trimethicone, C24-C28 methicone or stearyl dimethicone modified by a polyoxyalkylene group, e.g. cetyl dimethicone copolyol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
    • A61K8/89—Polysiloxanes
    • A61K8/895—Polysiloxanes containing silicon bound to unsaturated aliphatic groups, e.g. vinyl dimethicone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
    • A61K8/89—Polysiloxanes
    • A61K8/896—Polysiloxanes containing atoms other than silicon, carbon, oxygen and hydrogen, e.g. dimethicone copolyol phosphate
    • A61K8/897—Polysiloxanes containing atoms other than silicon, carbon, oxygen and hydrogen, e.g. dimethicone copolyol phosphate containing halogen, e.g. fluorosilicones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/007—Preparations for dry skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/20—Chemical, physico-chemical or functional or structural properties of the composition as a whole
    • A61K2800/30—Characterized by the absence of a particular group of ingredients
    • A61K2800/31—Anhydrous
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/52—Stabilizers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/59—Mixtures
    • A61K2800/594—Mixtures of polymers

Definitions

  • the present invention relates to a non-emulsified personal care composition
  • a non-emulsified personal care composition comprising an organic sunscreen and silicone elastomers.
  • Oily sunscreens including oil-soluble crystalline sunscreens, are desirable for their effectiveness, yet have an unpleasant skin feel and other undesirable characteristics associated with applying an oily composition to the skin.
  • Thickening oily sunscreens remains challenging, in particular when the sunscreen is present at higher, more effective concentrations. Whereas it may be possible to thicken an oil phase by using various types of waxy materials, these tend to exhibit instability at higher temperatures.
  • Sunscreen compositions in the form of an emulsion may have a less oily feel.
  • emulsions comprise water, emulsifiers, and aqueous thickeners. Water may promote the growth of microbes and thus shorten the shelf-life of the composition. Preservatives, emulsifiers and aqueous thickeners may have an unpleasant skin feel and/or may be irritating to the skin.
  • the present invention meets the aforementioned needs by providing a non-emulsified skin care composition
  • a non-emulsified skin care composition comprising an oil-soluble sunscreen, a non-polar emollient, a suitable sunscreen solvent, and emulsifying and non-emulsifying silicone elastomers.
  • the composition of the present invention provides a number of advantages. Because the composition is non-emulsified, the need for potentially irritating and unpleasant-feeling emulsifiers and preservatives is eliminated.
  • the sunscreen solvent solubilizes oily and crystalline sunscreens, and also is compatible with the silicone elastomers, which thicken the composition while providing a pleasant skin feel. The pleasant feel encourages frequent use of a sunscreen active, which provides a chronic benefit in the form of protection from harmful UV-radiation.
  • compositions which comprise waxy materials as primary thickeners are stable at higher temperatures and may not require heating during the manufacturing process (i.e. a "cold-filling" process may be used). This results in a lower cost and increased efficiency of production.
  • a personal care composition comprising from about 1% to about 20% of a non-emulsifying silicone elastomer; from about 0.5% to about 10% of an emulsifying silicone elastomer; from about 5% to about 30% of an oil-soluble sunscreen; from about 30% to about 80% of a non-polar emollient, and from about 1% to about 20% of a sunscreen solvent.
  • the composition is substantially anhydrous.
  • a method of providing a benefit to mammalian keratinous tissue in need thereof comprising the step of applying the composition of the first embodiment to keratinous tissue.
  • a kit comprising the composition of the first embodiment.
  • composition of the present invention may be used in skin care, cosmetic, and hair care products, non-limiting uses of which include moisturizers, conditioners, anti-aging compounds, skin lightening compounds, and combinations thereof.
  • the composition is applied to the face, neck, hands, arms and other areas of the body exposed to ultraviolet radiation.
  • the composition is applied to insult-affected areas of keratinous tissue.
  • personal care composition means compositions suitable for topical application on mammalian keratinous tissue.
  • the personal care compositions described herein may contain one or more skin care actives.
  • skin care actives or “actives,” as used herein, means compounds that aid in regulating the condition of skin and of other mammalian keratinous tissue, for example, by providing a benefit or improvement to the keratinous tissue.
  • Keratinous tissue refers to keratin-containing layers disposed as the outermost protective covering of mammals which includes, but is not limited to, skin, hair, nails, cuticles, etc.
  • stable and “stability” mean compositions which are substantially unaltered in chemical state, physical homogeneity and/or color, upon exposure to conditions reasonably expected to be incurred in shipping, storage and use, for example, for at least 30 days at a temperature of from about 0 0 C to about 40 0 C.
  • substantially free means that the compound of which the composition is substantially free is not added to the composition or phase; however, small amounts incidentally may be present, for example as a by-product of chemical reactions, or as a result of absorption from the surroundings. Alternatively, substantially free may be understood to mean less than about 1%, by weight of the phase.
  • substantially anhydrous means that water is not added to the composition; however, small amounts (typically less than 1%) incidentally may be present, for example, as a byproduct of chemical reactions, or as a result of absorption from the surroundings.
  • regulating the condition of keratinous tissue means improving the condition of mammalian keratinous tissue and/or prophylactically regulating the condition of mammalian keratinous tissue, and includes, for example, protecting the tissue from ultraviolet radiation, and regulating the signs of skin aging.
  • improving the condition of mammalian keratinous tissue means effecting a visually and/or tactilely perceptible positive change in the appearance and feel of the tissue.
  • Conditions that may be regulated and/or improved include, but are not limited to, one or more of the following: increasing the luminosity, or "glow" of the skin, reducing the appearance of wrinkles and coarse deep lines, fine lines, crevices, bumps, and large pores; thickening of keratinous tissue (e.g., building the epidermis and/or dermis and/or sub- dermal layers of the skin, and where applicable the keratinous layers of the nail and hair shaft, to reduce skin, hair, or nail atrophy); increasing the convolution of the dermal-epidermal border (also known as the rete ridges); preventing loss of skin or hair elasticity, for example, due to loss, damage and/or inactivation of functional skin elastin, resulting in such conditions as elastosis, sagging, loss of skin or hair recoil from deformation; reduction in cellulite; change in coloration to the skin, hair, or nails, for example, under-eye circles, blotchiness (e.
  • signs of skin aging include, but are not limited to, outward visibly and tactilely perceptible manifestations, as well as any macro- or microeffects, due to keratinous tissue aging. These signs may result from processes which include, but are not limited to, the development of textural discontinuities such as wrinkles and coarse deep wrinkles, fine lines, skin lines, crevices, bumps, large pores, unevenness or roughness; flaking; dryness; loss of skin elasticity; discoloration (including undereye circles); blotchiness; dullness or lack of luminosity, sallowness; hyperpigmented skin regions such as age spots and freckles; keratoses; abnormal differentiation; hyperkeratinization; elastosis; collagen breakdown, and other histological changes in the stratum corneum, dermis, epidermis, vascular system (e.g., telangiectasia or spider vessels), and underlying tissues (e.g., fat and/or muscle), especially those proximate
  • “Dermatologically-acceptable,” as used herein, means that the compositions or components thereof so described are suitable for use in contact with mammalian keratinous tissue without undue toxicity, incompatibility, instability, allergic response, and the like.
  • "Insult-affected keratinous tissue,” as used herein, means keratinous tissue which exhibits discomfort, irritation, an unpleasant or irregular appearance and the like, for example after exposure to a physical and/or chemical irritant.
  • the insult- affected keratinous tissue is human skin.
  • Non-limiting examples of insult- affected keratinous tissue include sunburn and other types of burns; rashes, such as diaper rash, shaving rash and allergen- induced rashes; discoloration, such as bleaching, staining or hyperpigmentation; nicks and cuts due to, for example, shaving; dry, chapped or rough skin due to exposure to example wind, cold and/or low humidity, etc.
  • Non-limiting examples of insults include ultraviolet radiation, wind, low humidity, allergens, pollutants, chemical and natural irritants, bodily fluids, bodily waste, excessive moisture, bacteria, fungi, etc.
  • kit means a packaging unit comprising at least one composition described herein.
  • the kit may comprise a plurality of components, including a composition described herein.
  • the kit further may comprise one or more additional compositions, suitable for application prior to or after application of the composition described herein, one or more orally ingestible dietary supplements, a delivery enhancement device, instructions for use of the device, instructions for complying with suitable application regimens, and combinations thereof.
  • the composition of the present invention may have a viscosity of from about 10,000 cps (centipoise) to about 1,000,000 cps, alternatively from about 30,000 cps to about 500,000 cps, and alternatively from about 40,000 cps to about 200,000 cps.
  • the composition may be substantially free from surfactants and/or emulsifiers.
  • the composition may be substantially free from waxes.
  • the composition may exhibit stability at a temperature of up to about 45°C, and the manufacturing process may proceed occur without the step of heating the composition above room temperature, or about 25°C (also referred to as "cold processing.")
  • the composition is substantially anhydrous, to increase stability of the sunscreen and of the composition, and to increase the pleasant feel characteristics of the composition.
  • the composition of the present invention comprises a silicone elastomer, useful for reducing the tackiness of the composition and for providing a pleasant feel upon application.
  • a silicone elastomer useful for reducing the tackiness of the composition and for providing a pleasant feel upon application.
  • One non-limiting example of useful silicone elastomers is crosslinked organopolysiloxane (or siloxane) elastomers, as described in U.S. patent publication 2003/0049212A1.
  • the elastomers may comprise emulsifying and non-emulsifying silicone elastomers.
  • 'Emulsifying means crosslinked organopolysiloxane elastomers having at least one polyoxyalkylene (e.g., polyoxyethylene or polyoxypropylene) or polyglycerin moiety, whereas "non-emulsifying" means crosslinked organopolysiloxane elastomers essentially free of polyoxyalkylene or polyglycerin moeities.
  • composition of the present invention may comprise from about 1% to about 20%, and alternatively from about 5% to about 15%, of a non-emulsifying crosslinked organopolysiloxane elastomer.
  • suitable non-emulsifying crosslinked organopolysiloxane elastomers include dimethicone crosspolymers, dimethicone/vinyl dimethicone crosspolymers, and copolymers, derivatives and mixtures thereof, supplied by Dow CorningTM (e.g.
  • VelvesilTM 125 and VelvesilTM DM dimethicone/phenyl vinyl dimethicone crosspolymer, vinyl dimethicone/lauryl dimethicone crosspolymer, trifluoropropyl dimethicone/trifluoropropyl divinyldimethicone crosspolymer, and copolymers, derivatives and mixtures thereof, supplied by Shin EtsuTM (KSG-15, -15AP, -16, -17, -18, -41, -42, -43, -44, -51, -103), and the Grant Industries line of elastomers, available as GRANSILTM.
  • composition of the present invention may comprise from about 0.5% to about 10%, and alternatively from about 1% to about 5%, of an emulsifying crosslinked organopolysiloxane elastomer, described in US Patents 5,412,004; 5,837,793; and 5,811,487.
  • Non-limiting examples of suitable emulsifying elastomers include PEG- 12 dimethicone crosspolymers, supplied by Dow CorningTM (DC 9010 and 9011) dimethicone/PEG-10/15 crosspolymer, dimethicone/PEG-10 crosspolymer, PEG-15/lauryl dimethicone crosspolymer, trifluoropropyl dimethicone/PEG-10 crosspolymer, dimethicone/polyglycerin-3 crosspolymer, lauryl dimethicone/polyglycerin-3 crosspolymer, all supplied by Shin EtsuTM (KSG-24, -61, -21/210, -31/310, -32/320, -33/330, - 34/340, -710, -810, -820, -830, and -840); polyoxyalkylene-modified elastomers formed from divinyl compounds, e.g.
  • siloxane polymers with at least two free vinyl groups bonded via Si-H linkages on a polysiloxane backbone are dimethyl polysiloxanes crosslinked by Si-H sites on a molecularly spherical MQ resin (R3SiOi/ 2 SiO 4 ⁇ ), and alternatively is dimethicone copolyol crosspolymer and dimethicone, commercially available from Shin Etsu as KSG-21.
  • R3SiOi/ 2 SiO 4 ⁇ molecularly spherical MQ resin
  • dimethicone copolyol crosspolymer and dimethicone commercially available from Shin Etsu as KSG-21.
  • the composition of the present invention comprises from about 5% to about 30%, alternatively from about 5% to about 20%, and alternatively from about 5% to about 15%, of at least one oil-soluble sunscreen.
  • sunscreen is understood to include both sunscreens and UV-light absorbers.
  • the composition comprises at least one sunscreen which, in its commercially-available purified form, is an oil-soluble crystalline and/or solid compound. It is to be understood that the crystalline sunscreen is substantially dissolved, and thus does not remain in a crystalline form, in the final composition.
  • the composition comprises at least 2%, alternatively from about 2% to about 15%, and alternatively from about 2% to about 10%, of an oil-soluble, crystalline sunscreen.
  • Non-limiting examples of suitable oil-soluble sunscreens are disclosed in The Cosmetic, Toiletry, and Fragrance Association's The International Cosmetic Ingredient Dictionary and Handbook, 10 th Ed., Gottschalck, T.E. and McEwen, Jr., Eds. (2004), p. 2267 and pp.
  • 2292-93 and include benzophenone-3, bis-ethylhexyloxyphenol methoxyphenyl triazine, butyl methoxydibenzoyl- methane, diethylamino hydroxy-benzoyl hexyl benzoate, drometrizole trisiloxane, ethylhexyl methoxy-cinnamate, ethylhexyl salicylate, ethylhexyl triazone, octocrylene, homosalate, polysilicone-15, oxybenzone, and derivatives and mixtures thereof.
  • benzophenone-3 bis-ethylhexyloxyphenol methoxyphenyl triazine
  • butyl methoxydibenzoyl- methane diethylamino hydroxy-benzoyl hexyl benzoate
  • drometrizole trisiloxane ethylhexyl
  • composition further may comprise from about 0.001% to about 10%, and alternatively from about 0.1% to about 5%, of an inorganic and/or oil-insoluble sunscreen.
  • suitable insoluble sunscreens include methylene bis-benzotriazolyl tetramethylbutyl-phenol, titanium dioxides, zinc cerium oxides, zinc oxides, and derivatives and mixtures thereof. It is to be understood that "oil-insoluble sunscreen” does not encompass water- soluble sunscreens.
  • Non-polar Emollient The composition of the present invention comprises from about 30% to about 80% of a non-polar emollient.
  • suitable non-polar emollients include silicone oils, hydrocarbon oils, and mixtures thereof.
  • Useful non-polar emollients in the present invention include natural, synthetic, saturated, unsaturated, straight chained, branched chained, linear, cyclic, aromatic, volatile, and non-volatile non-polar emollients, and mixtures thereof.
  • “Non- polar,” as used herein, means that the solvent has an average solubility parameter of from about 5 to about 8 (cal/cm 3 ) 0 , where "cal” means calories. Solubility parameters are discussed in more detail by C. D. Vaughan in 'The Solubility Parameter: What is it?," Cosmetics & Toiletries vol. 106, November, 1991, pp. 69-72.
  • Non-limiting examples of suitable non-polar hydrocarbons include mineral oils and branched chain hydrocarbons.
  • Mineral oils include petroleum derivatives which are mixtures of paraffinic and naphthenic (cyclic) hydrocarbons. These include both 'light" and 'heavy" mineral oils, which are differentiated on the basis of the average molecular weight of the hydrocarbon mixture.
  • Non-limiting examples of suitable branched chain hydrocarbons include hydrocarbon liquids containing from about 10 to about 68 carbons, and alternatively from 10 to about 24 carbons, commercially available, for example, under the tradenames PermethylTM (Permethyl CorporationTM) and IsoparTM (ExxonTM).
  • Non-limiting examples of suitable non-polar silicones useful in the present invention include those disclosed in U.S. Patent 4,781,917 issued to Luebbe et al. Additionally, a description of various silicones materials is found in Todd et al., "Volatile Silicone Fluids for Cosmetics", Cosmetics and Toiletries, 91:27-32 (1976).
  • the silicone oils are selected from the group consisting of cyclic silicones corresponding to the formula:
  • n is from about 3 to about 7; and linear silicones corresponding to the formula:
  • Non-limiting examples of additional non-polar silicones useful in the present invention include alkyl (for example, 2 carbons to 30 carbons) and aryl (for example, phenyl or styrenyl) substituted silicones, including by not limited to phenyl methicone, phenyl dimethicone, phenyl trimethicone, diphenyl dimethicone, phenylethyl dimethicone, hexyl dimethicone, lauryl dimethicone, cetyl dimethicone, stearyl dimethicone, bis-stearyl dimethicone, and mixtures thereof.
  • composition of the present invention comprises from about 1% to about 20%, and alternatively from about 5% to about 15%, of a sunscreen solvent, which is compatible with the non-polar emollients and elastomers described herein, and is suitable to substantially solubilize the oil-soluble sunscreen.
  • sunscreen solvent as used herein, may be understood to mean that in a solution comprising about 90% of the neat sunscreen solvent and about 10% of butyl methoxydibenzoyl-methane, both by weight of the composition, the butyl methoxydibenzoyl- methane is substantially soluble at room temperature, i.e. is no longer visible as a solid material to the naked eye by one having unimpaired vision.
  • sunscreen solvents include butyl and isopropyl phthalimide (PelemolTM BIP), phenylethyl benzoate (X-tendTM 226), dicaprylyl carbonate
  • compositions of the present invention may comprise from about 0.001% to about 40%, alternatively from about 3% to about 30%, and alternatively from about 5% to about 20%, of one or more particulate materials and/or cosmetic powders.
  • suitable powders include inorganic powders (for example, iron oxides, titanium dioxides, zinc oxides, silica), organic powders, composite powders, optical brightener particles, and mixtures of any of the foregoing.
  • particulates can, for instance, be platelet shaped, spherical, elongated or needle-shaped, or irregularly shaped; surface coated or uncoated; porous or non-porous; charged or uncharged; and can be added to the current compositions as a powder or as a pre-dispersion.
  • the particulate material is hydrophobically coated.
  • Suitable organic powders particulate materials include, but are not limited, to polymeric particles chosen from the methylsilsesquioxane resin microspheres, for example, TospearlTM 145A, (Toshiba Silicone); microspheres of polymethylmethacrylates, for example, MicropearlTM
  • M 100 (Seppic); the spherical particles of crosslinked polydimethylsiloxanes, for example, TrefilTM E 506C or TrefilTM E 505C (Dow Corning Toray Silicone); sphericle particles of polyamide, for example, nylon- 12, and OrgasolTM 2002D Nat C05 (Atochem); polystyrene microspheres, for example Dyno Particles, sold under the name DynospheresTM, and ethylene acrylate copolymer, sold under the name FIoB eadTM EA209 (Kobo); aluminium starch octenylsuccinate, for example Dry FloTM (National Starch); microspheres of polyethylene, for example MicrotheneTM FN510-00 (Equistar), silicone resin, polymethylsilsesquioxane silicone polymer, platelet shaped powder made from L-lauroyl lysine, and mixtures thereof.
  • polyamide for example, nylon- 12, and Or
  • the composition of the present invention further may comprise interference pigments, including hydrophobically-modified interference pigments.
  • interference pigments means thin, platelike layered particles having two or more layers of controlled thickness. The layers have different refractive indices that yield a characteristic reflected color from the interference of typically two, but occasionally more, light reflections, from different layers of the platelike particle.
  • interference pigments are micas layered with about 50 - 300 nm films of TiO 2 , Fe 2 ⁇ 3 , silica, tin oxide, and/or Cr 2 O 3 and include pearlescent pigments.
  • Intereference pigments are available commercially from a wide variety of suppliers, for example, Rona (TimironTM and DichronaTM), Presperse (FlonacTM), Englehard (DuochromeTM), Kobo (SK- 45-R and SK-45-G), BASF (SicopearlsTM) and Eckart (PrestigeTM).
  • the average diameter of the longest side of the individual particles of interference pigments is less than about 75 microns, and alternatively less than about 50 microns.
  • composition of the present invention may comprise from about 0.001% to about 25%, and alternatively from about 0.01% to about 5%, of a colorant.
  • the colorant may be oil- soluble, or may be hydrophobically modified to increase oil- solubility.
  • suitable colorants include, but are not limited to organic and/or inorganic pigments, natural and/or synthetic dyes, lakes, including FD&C and/or D&C lakes and blends, and mixtures of any of the foregoing.
  • Non-limiting examples of suitable colorants include iron oxides, ferric ammonium ferrocyanide, manganese violet, ultramarine blue, and chromium oxide, phthalocyanine blue and green pigment, encapsulated dyes, inorganic white pigments, for example TiO 2 , ZnO, or ZrO 2 , FD&C dyes, D&C dyes, and mixtures thereof. 4. Additional Skin Care Active
  • the composition of the present invention may comprise at least one additional skin care active.
  • the skin care active should be soluble in and compatible with the elastomers and other components of the composition to produce a dermatologically-acceptable composition. Solubility is within the knowledge of one of skill in the art, and can be determined using known methods of analysis. One of skill in the art further will understand that solubility may be affected by the concentration of the skin care active, and the type and concentration of other components in the composition. Many skin care actives may provide more than one benefit, or operate via more than one mode of action; therefore, classifications herein are made for the sake of convenience and are not intended to limit the active to that particular application or applications listed. Vitamins
  • compositions of the present invention may comprise from about 0.0001% to about 50%, alternatively from about 0.001% to about 10%, and alternatively from about 0.01% to about 5%, of one or more vitamins.
  • vitamins means vitamins, pro-vitamins, and their salts, isomers and derivatives.
  • Non-limiting examples of suitable vitamins include: vitamin B compounds (including Bl compounds, B2 compounds, B3 compounds such as niacinamide, niacinnicotinic acid, tocopheryl nicotinate, Cl -C 18 nicotinic acid esters, and nicotinyl alcohol; B5 compounds, such as panthenol or "pro-B5", pantothenic acid, pantothenyl; B6 compounds, such as pyroxidine, pyridoxal, pyridoxamine; carnitine, thiamine, riboflavin); vitamin A compounds, and all natural and/or synthetic analogs of Vitamin A, including retinoids, retinol, retinyl acetate, retinyl palmitate, retinoic acid, retinaldehyde, retinyl propionate, carotenoids (provitamin A), and other compounds which possess the biological activity of Vitamin A; vitamin D compounds; vitamin K compounds; vitamin E compounds, or to
  • the composition comprises a vitamin selected from the group consisting of vitamin B compounds, vitamin C compounds, vitamin E compounds and mixtures thereof.
  • the vitamin is selected from the group consisting of niacinamide, tocopheryl nicotinate, pyroxidine, panthenol, vitamin E, vitamin E acetate, ascorbyl phosphates, ascorbyl glucoside, and mixtures thereof.
  • compositions of the present invention may comprise one or more peptides.
  • peptide refers to peptides containing ten or fewer amino acids, their derivatives, isomers, and complexes with other species such as metal ions (for example, copper, zinc, manganese, and magnesium).
  • metal ions for example, copper, zinc, manganese, and magnesium.
  • peptide refers to both naturally occurring and synthesized peptides.
  • the peptides are di-, tri-, tetra-, penta-, and hexa-peptides, their salts, isomers, derivatives, and mixtures thereof.
  • useful peptide derivatives include, but are not limited to, peptides derived from soy proteins, carnosine (beta-alanine-histidine), palmitoyl-lysine-threonine (pal-KT) and palmitoyl-lysine-threonine-threonine-lysine-serine (pal- KTTKS, available in a composition known as MATRIXYL ), palmitoyl-glycine-glutamine- proline-arginine (pal-GQPR, available in a composition known as RIGIN ® ), these three being available from Sederma, France, acetyl-glutamate-glutamate-methionine-glutamine-arginine- arginine (Ac-EEMQRR; Argireline®), and Cu-histidine-glycine-glycine (Cu-HGG, also known as IAMIN ® ).
  • compositions may comprise from about lxl ⁇ ⁇ 7 % to about 20%, alternatively from about 1x10 " % to about 10%, and alternatively from about 1x10 " % to about 5% of the peptide.
  • Sugar Amines The compositions of the present invention may comprise a sugar amine, also known as amino sugars, and their salts, isomers, tautomers and derivatives.
  • Sugar amines can be synthetic or natural in origin and can be used as pure compounds or as mixtures of compounds (e.g., extracts from natural sources or mixtures of synthetic materials). For example, glucosamine is generally found in many shellfish and can also be derived from fungal sources.
  • Sugar amine compounds useful in the present invention include, for example, N-acetyl-glucosamine, and also those described in PCT Publication WO 02/076423 and U.S. Patent No. 6,159,485, issued to Yu, et al.
  • the composition comprises from about 0.01% to about 15%, alternatively from about 0.1% to about 10%, and alternatively from about 0.5% to about 5%, of the sugar amine.
  • Oil control agents The compositions of the present invention may comprise one or more compounds useful for regulating the production of skin oil, or sebum, and for improving the appearance of oily skin.
  • suitable oil control agents include salicylic acid, dehydroacetic acid, benzoyl peroxide, vitamin B3 compounds (for example, niacinamide or tocopheryl nicotinate), their isomers, esters, salts and derivatives, and mixtures thereof.
  • the compositions may comprise from about 0.0001% to about 15%, alternatively from about 0.01% to about 10%, alternatively from about 0.1% to about 5%, and alternatively from about 0.2% to about 2%, of an oil control agent.
  • compositions of the present invention further may comprise non- vitamin antioxidants and radical scavengers, hair growth regulators, flavonoids, minerals, preservatives, phytosterols and/or plant hormones, protease inhibitors, tyrosinase inhibitors, anti-inflammatory agents and N- acyl amino acid compounds.
  • Suitable non-vitamin antioxidants and radical scavengers include, but are not limited to, BHT (butylated hydroxy toluene), L-ergothioneine (available as THIOTANETM); tetrahydrocurcumin, cetyl pyridinium chloride, carnosine, diethylhexyl syrinylidene malonate
  • ARLATONETM Dioic DCA from Uniqema ubiquinone (co-enzyme QlO), tea extracts including green tea extract, yeast extracts or yeast culture fluid (e.g., Pitera®), and combinations thereof.
  • Suitable hair growth regulators include, but are not limited to, hexamidine, butylated hydroxytoluene (BHT), hexanediol, panthenol and pantothenic acid derivates, their isomers, salts and derivatives, and mixtures thereof.
  • Suitable minerals include zinc, manganese, magnesium, copper, iron, selenium and other mineral supplements. "Mineral” is understood to include minerals in various oxidation states, mineral complexes, salts, derivatives, and combinations thereof.
  • Suitable examples of plant sterols (phytosterols) and/or plant hormones include, but are not limited to, sitosterol, stigmasterol, campesterol, brassicasterol, kinetin, zeatin, and mixtures thereof.
  • Suitable protease inhibitors include, but are not limited to, hexamidine, vanillin acetate, menthyl anthranilate, soybean trypsin inhibitor, Bowman-Birk inhibitor, and mixtures thereof.
  • Suitable tyrosinase inhibitors include, but are not limited to, sinablanca (mustard seed extract), tetrahydrocurcumin, cetyl pyridinium chloride, and mixtures thereof.
  • Suitable anti-inflammatory agents include, but are not limited to, glycyrrhizic acid (also known as glycyrrhizin, glycyrrhixinic acid, and glycyrrhetinic acid glycoside), glycyrrhetenic acid, other licorice extracts, and combinations thereof.
  • glycyrrhizic acid also known as glycyrrhizin, glycyrrhixinic acid, and glycyrrhetinic acid glycoside
  • glycyrrhetenic acid other licorice extracts, and combinations thereof.
  • Suitable N-acyl amino acid compounds include, but are not limited to, N-acyl phenylalanine, N-acyl tyrosine, their isomers, including their D and L isomers, salts, derivatives, and mixtures thereof.
  • An example of a suitable N-acyl amino acid is N-undecylenoyl-L- phenylalanine is commercially available under the tradename SEPIWHITE® from Seppic (France).
  • moisturizing and/or conditioning agents such as glycerol, petrolatum, caffeine, and urea; yeast extracts (for example, PiteraTM); dehydroepiandrosterone (DHEA), its analogs and derivatives; exfoliating agents, including alpha- and beta-hydroxyacids, alpha-keto acids, glycolic acid and octanoyl salicylate; antimicrobial agents; antidandruff agents such as piroctone olamine, 3,4,4'-trichlorocarbanilide (trichlosan), triclocarban and zinc pyrithione; dimethyl aminoethanol (DMAE); creatine; skin lightening agents such as kojic acid, mulberry extract, hydroquinone, arbutin, and deoxy-arbutin; (sunless) tanning agents, such as dihydroxy acetone (DHA); isomers, salts, and derivatives of any of the foregoing; and mixtures thereof.
  • moisturizing and/or conditioning agents such as g
  • the present invention describes a method of providing a benefit to mammalian keratinous tissue, including a method of protecting the mammalian skin from the effects of ultraviolet radiation, comprising the step of topically applying to mammalian skin a personal care composition described herein.
  • the method may comprise the step of applying the composition described herein to insult- affected keratinous tissue, to regulate and/or improve the condition of such tissue, and/or to provide relief from the effects of the insult.
  • Benefits include regulating and/or improving the condition of keratinous tissue, non- limiting examples of which include reducing the appearance of wrinkles, reducing the appearance of deep lines, reducing the appearance of fine lines, reducing the appearance of large pores, reducing the thickness of keratinous tissue, increasing the convolution of the dermal-epidermal border, increasing elasticity, reducing the appearance of cellulite, reducing the appearance of discoloration, reducing the appearance of hyperpigmentation, reducing the appearance of under- eye circles, reducing the appearance of sallowness, and combinations thereof.
  • the benefit may include reducing wrinkles, reducing deep lines, reducing fine lines, reducing large pores, reducing cellulite, reducing hyperpigmentation, reducing undereye circles, reducing puffiness, and combinations thereof.
  • the composition may be applied by a variety of means, including by rubbing, wiping or dabbing with hands or fingers, or by means of an implement and/or delivery enhancement device.
  • implements include a sponge or sponge-tipped applicator, a swab (for example, a cotton-tipped swab), a pen optionally comprising a foam or sponge applicator, a brush, a wipe, and combinations thereof.
  • delivery enhancement devices include mechanical, electrical, ultrasonic and/or other energy devices. After application, the composition may be allowed to remain on the keratinous tissue.
  • the amount of the composition applied, the frequency of application and the period of use will vary widely depending upon the level of components of a given composition and the level of regulation desired. For example, from about 0.1 mg composition/cm 2 to about 50 mg composition/cm 2 , and alternatively about 2 mg composition/cm 2 of keratinous tissue may be applied.
  • the composition is applied prior to exposure of the skin to ultraviolet radiation, and alternatively at least once daily, where "daily" and "days" mean a 24- hour period.
  • the user may be instructed to reapply the composition after a period of time has passed, for example every hour, and alternatively when the composition has been washed or rinsed from the skin, for example after washing one's hands or after swimming.
  • the composition further may be applied as part of a treatment regimen, for example, once daily for 30 consecutive days, alternatively for 14 consecutive days, alternatively for 7 consecutive days and alternatively for 2 consecutive days.
  • the method may comprise the step of inducing a temperature change in the composition and/or in the keratinous tissue either simultaneously or sequentially with the step of applying the composition.
  • the method further may comprise additional steps which form part of a treatment or application regimen, including the steps of applying at least one additional composition, ingesting one or more dietary supplements, cleansing, etc. in. Kit
  • the present invention further provides a kit comprising at least one composition described herein.
  • the kit may comprise an outer packaging unit, which in turn may comprise one or more inner packaging units.
  • at least a portion of all packaging is transparent or translucent, such that the composition is visible to a consumer.
  • a suitable outer container is a box or a tray, suitable for holding a sufficient number of inner packaging units for an indicated application regimen, for example, one application per day for one month.
  • the tray may contain an array of individual inner packaging units which are organized to correspond to an indicated application regimen.
  • the kit further may comprise an implement, which may be suitable for targeted delivery of the composition to a desired area of keratinous tissue.
  • the composition may be packaged separately from the implement, or may be contained within the implement.
  • the kit further may comprise a plurality of components, including one or more additional compositions, one or more orally ingestible dietary supplements, an additional implement, an additional delivery enhancement device, a temperature change element, a substrate, instructions for complying with suitable application regimens, and combinations thereof.
  • additional compositions including one or more orally ingestible dietary supplements, an additional implement, an additional delivery enhancement device, a temperature change element, a substrate, instructions for complying with suitable application regimens, and combinations thereof.
  • compositions may be stored in a suitable container, and applied for example to mammalian skin exposed or expected to be exposed to ultraviolet radiation, to insult- affected skin, and/or to skin in need of a particular benefit, including aged skin.
  • Anhydrous sunscreen compositions may be prepared by conventional methods (by combining all ingredients and thoroughly mixing, as would be known to one of skill in the art) from the following components:
  • composition may comprise one or more other skin care actives, their salts and derivatives, as disclosed herein, in amounts also disclosed herein as would be deemed suitable by one of skill in the art.
  • Sunscreen compositions may be prepared by conventional methods (by combining all ingredients and thoroughly mixing, as would be known to one of skill in the art) from the following components:
  • Zinc Oxide and Triethoxycaprylylsilane from BASFTM 5.5% Dimethicone / Vinyl Dimethicone Crosspolymer in Cyclomethicone from Shin-EtsuTM 3 15% Dimethicone / Phenyl Vinyl Dimethicone Crosspolymer in Phenyl Trimethicone from Shin-EtsuTM 4 25% Dimethicone / Polyglycerin-3 Crosspolymer in Dimethicone from Shin-EtsuTM
  • composition may comprise one or more other skin care actives, their salts and derivatives, as disclosed herein, in amounts also disclosed herein as would be deemed suitable by one of skill in the art.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Emergency Medicine (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Cosmetics (AREA)

Abstract

L'invention concerne une composition stable pour soins personnels comprenant entre environ 1% et environ 20% d'un élastomère de silicone non émulsifiant, entre environ 0,5% et environ 10% d'un élastomère de silicone émulsifiant, entre environ 5% et environ 30% d'un écran solaire soluble dans l'huile, entre environ 1% et environ 20% d'un solvant pour écran solaire, et entre environ 30% et environ 80% d'un émollient non polaire.
PCT/IB2007/052377 2006-06-22 2007-06-20 Composition pour soins personnels WO2007148293A2 (fr)

Priority Applications (3)

Application Number Priority Date Filing Date Title
CA002654291A CA2654291A1 (fr) 2006-06-22 2007-06-20 Composition pour soins personnels
MX2009000126A MX2009000126A (es) 2006-06-22 2007-06-20 Composicion para el cuidado personal.
EP07789751A EP2029238A2 (fr) 2006-06-22 2007-06-20 Composition pour soins personnels

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11/472,739 US20070297997A1 (en) 2006-06-22 2006-06-22 Personal care composition
US11/472,739 2006-06-22

Publications (2)

Publication Number Publication Date
WO2007148293A2 true WO2007148293A2 (fr) 2007-12-27
WO2007148293A3 WO2007148293A3 (fr) 2008-05-22

Family

ID=38833842

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IB2007/052377 WO2007148293A2 (fr) 2006-06-22 2007-06-20 Composition pour soins personnels

Country Status (7)

Country Link
US (1) US20070297997A1 (fr)
EP (1) EP2029238A2 (fr)
KR (1) KR20090006226A (fr)
CN (1) CN101472650A (fr)
CA (1) CA2654291A1 (fr)
MX (1) MX2009000126A (fr)
WO (1) WO2007148293A2 (fr)

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2920984A1 (fr) * 2007-09-19 2009-03-20 Oreal Composition comprenant une phase grasse continue et un ester particulier
WO2009038712A1 (fr) * 2007-09-20 2009-03-26 Momentive Performance Materials Inc. Composition de gel de silicone contenant du nitrure de bore
FR2933614A1 (fr) * 2008-07-10 2010-01-15 Oreal Kit de protection solaire.
WO2013068237A1 (fr) 2011-11-07 2013-05-16 L'oreal Composition à phase huileuse continue contenant au moins un agent d'écrantage uv organique lipophile et des particules d'aérogel de silice hydrophobe
WO2011150034A3 (fr) * 2010-05-27 2013-07-11 Johnson & Johnson Consumer Companies, Inc. Composition anhydre comprenant un composé de dibenzoylméthane et un pigment coloré
FR2988600A1 (fr) * 2012-03-30 2013-10-04 Oreal Composition a effet matifiant comprenant un ester d'acide amine n-acyle

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101568326A (zh) * 2006-12-21 2009-10-28 宝洁公司 包含硅氧烷弹性体的个人护理组合物
US8469621B2 (en) * 2007-02-27 2013-06-25 The Procter & Gamble Company Personal care product having a solid personal care composition within a structure maintaining dispenser
EP2384193A4 (fr) 2009-01-05 2013-05-22 Ernest T Armstrong Ecran solaire favorisant la vitamine d
US9833391B2 (en) * 2009-03-20 2017-12-05 The Proctor & Gamble Company Personal-care composition comprising a hydrocarbon wax and a polar oil
US8088364B2 (en) * 2009-03-20 2012-01-03 The Procter & Gamble Company Personal-care composition comprising oil-soluble solid sunscreens
WO2010111266A2 (fr) * 2009-03-23 2010-09-30 The Procter & Gamble Company Composition de soins personnels comprenant un actif cationique
US20100305169A1 (en) * 2009-03-23 2010-12-02 Larry Rich Robinson Personal-care composition comprising a cationic active
FR2953715B1 (fr) * 2009-12-11 2012-02-17 Oreal Composition filtrante fluide anhydre comprenant une phase huileuse, un filtre triazine particulier et un agent rheologique epaississant ou gelifiant d'huile
KR101809628B1 (ko) * 2010-05-17 2017-12-15 마리 케이 인코포레이티드 국소 피부 제형
US8524203B2 (en) * 2010-09-23 2013-09-03 Conopco, Inc. Sunscreen composite particles for UVA and UVB protection
US20140227208A1 (en) * 2013-02-08 2014-08-14 The Procter & Gamble Company Cosmetic compositions containing substituted azole and methods for alleviating mechanically-induced skin inflammation
US9168211B2 (en) 2014-03-28 2015-10-27 Johnson & Johnson Consumer Inc. Method of making an anhydrous, pigmented composition
US20160120791A1 (en) * 2014-10-30 2016-05-05 L'oreal Anhydrous alcohol-free sunscreen composition for application onto wet or dry skin
JP6899200B2 (ja) * 2015-04-28 2021-07-07 ロート製薬株式会社 外用組成物、及びそれを用いたメイクアップ用化粧料
US9655825B2 (en) 2015-06-19 2017-05-23 L'oreal Sunscreen composition containing high levels of liposoluble UV filters
US9649263B2 (en) 2015-06-19 2017-05-16 L'oreal Sunscreen composition containing high levels of liposoluble UV filters
CN106377440A (zh) * 2015-07-31 2017-02-08 上海家化联合股份有限公司 一种稳定的防晒剂组合物
WO2024165290A1 (fr) 2023-02-07 2024-08-15 Unilever Ip Holdings B.V. Composition de soins personnels sans eau

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6409997B1 (en) 2000-07-31 2002-06-25 Neutrogena Corporation Wax cosmetic stick

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4120948A (en) * 1976-11-29 1978-10-17 The Procter & Gamble Company Two phase antiperspirant compositions
EP0545002A1 (fr) * 1991-11-21 1993-06-09 Kose Corporation Polymère de silicone, composition pâteuse et composition cosmétique du type eau-dans-l'huile le contenant
US5599525A (en) * 1994-11-14 1997-02-04 Colgate Palmolive Company Stabilized dentifrice compositions containing reactive ingredients
US6221979B1 (en) * 1999-11-08 2001-04-24 Dow Corning Corporation Mixtures of silicone elastomers
US6281239B1 (en) * 2000-04-12 2001-08-28 Bradley Pharmeaceuticals, Inc. Method of treating onychomycosis
US6524598B2 (en) * 2000-07-10 2003-02-25 The Procter & Gamble Company Cosmetic compositions
US20020022040A1 (en) * 2000-07-10 2002-02-21 The Proctor & Gamble Company Methods of enhancing delivery of oil-soluble skin care actives
WO2002003930A2 (fr) * 2000-07-10 2002-01-17 The Procter & Gamble Company Procedes destines a ameliorer l'administration d'agents actifs solubles dans l'huile destines au soin de la peau
US6696049B2 (en) * 2000-07-10 2004-02-24 The Procter & Gamble Company Cosmetic compositions
US6830746B2 (en) * 2001-09-21 2004-12-14 Playtex Products, Inc. Sunscreen compositions
US6776981B2 (en) * 2002-01-29 2004-08-17 The Gillette Company Personal care product
US6537529B1 (en) * 2002-03-05 2003-03-25 The C.P. Hall Company Sunscreen compositions and methods and materials for producing the same
US7153494B2 (en) * 2002-10-21 2006-12-26 L'oreal Dibenzoylmethane sunscreen compositions photostabilized with amphiphilic block copolymers
US20040228821A1 (en) * 2003-05-16 2004-11-18 The Procter & Gamble Company Personal care products comprising active agents in a gel network
US7132097B2 (en) * 2004-10-08 2006-11-07 Isp Investments Inc. Sunscreen compositions
MXPA06002701A (es) * 2003-09-10 2006-06-06 Procter & Gamble Composicion para el cuidado de la piel.
ES2633640T3 (es) * 2004-03-22 2017-09-22 L'oreal Composición cosmética que comprende un elastómero de silicona poliglicerolado
US20050281763A1 (en) * 2004-06-17 2005-12-22 Yasuko Suginaka Personal care compositions comprising sparingly soluble solid oily components and solvents thereof
FR2885797B1 (fr) * 2005-05-17 2007-07-27 Oreal Particules d'huile gelifiee comportant au moins un filtre solaire hydrophobe

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6409997B1 (en) 2000-07-31 2002-06-25 Neutrogena Corporation Wax cosmetic stick

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2920984A1 (fr) * 2007-09-19 2009-03-20 Oreal Composition comprenant une phase grasse continue et un ester particulier
WO2009038712A1 (fr) * 2007-09-20 2009-03-26 Momentive Performance Materials Inc. Composition de gel de silicone contenant du nitrure de bore
TWI482808B (zh) * 2007-09-20 2015-05-01 Momentive Performance Mat Inc 含氮化硼之聚矽氧烷凝膠組成物
FR2933614A1 (fr) * 2008-07-10 2010-01-15 Oreal Kit de protection solaire.
EP2153817A1 (fr) * 2008-07-10 2010-02-17 L'oreal Kit de protection solaire
US9192551B2 (en) 2008-07-10 2015-11-24 L'oreal Sun protection kit
WO2011150034A3 (fr) * 2010-05-27 2013-07-11 Johnson & Johnson Consumer Companies, Inc. Composition anhydre comprenant un composé de dibenzoylméthane et un pigment coloré
WO2013068237A1 (fr) 2011-11-07 2013-05-16 L'oreal Composition à phase huileuse continue contenant au moins un agent d'écrantage uv organique lipophile et des particules d'aérogel de silice hydrophobe
FR2988600A1 (fr) * 2012-03-30 2013-10-04 Oreal Composition a effet matifiant comprenant un ester d'acide amine n-acyle

Also Published As

Publication number Publication date
EP2029238A2 (fr) 2009-03-04
WO2007148293A3 (fr) 2008-05-22
CA2654291A1 (fr) 2007-12-27
US20070297997A1 (en) 2007-12-27
CN101472650A (zh) 2009-07-01
MX2009000126A (es) 2009-01-26
KR20090006226A (ko) 2009-01-14

Similar Documents

Publication Publication Date Title
US20070297997A1 (en) Personal care composition
US20070297996A1 (en) Multi-phase composition comprising a sunscreen
US20070264210A1 (en) Method of enhancing penetration of water-soluble actives
US8088364B2 (en) Personal-care composition comprising oil-soluble solid sunscreens
US20080038360A1 (en) Personal care composition
US20080038216A1 (en) Personal care composition
US20080299058A1 (en) Multi-formulation cosmetic compositions
US20070253914A1 (en) Method of exfoliation
JP2006528935A (ja) Ｎ−アシルアミノ酸組成物を用いた哺乳類のケラチン組織の調整
US20110033512A1 (en) Personal care composition with improved spreadability
US20090011035A1 (en) Personal care composition
CA2672038A1 (fr) Composition huile-dans-l'eau de soin personnel
CN105899187B (zh) 用于改善人体皮肤外观和感觉的多步方案
CN103841949A (zh) 具有不含硅酮乳化剂的天然乳化剂系统的个人组合物
CN103857377A (zh) 具有不含硅酮乳化剂的天然乳化剂系统的个人组合物
EP2854755B1 (fr) Produits cosmétiques pour réduire l'apparition de poils
CN106659644B (zh) 用于改善人体皮肤外观和感觉的多步方案
US20070196292A1 (en) Personal care composition comprising dehydroacetate salts

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 200780023328.3

Country of ref document: CN

121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 07789751

Country of ref document: EP

Kind code of ref document: A2

WWE Wipo information: entry into national phase

Ref document number: 2007789751

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 9951/DELNP/2008

Country of ref document: IN

WWE Wipo information: entry into national phase

Ref document number: 1020087029459

Country of ref document: KR

WWE Wipo information: entry into national phase

Ref document number: 2654291

Country of ref document: CA

NENP Non-entry into the national phase

Ref country code: DE

WWE Wipo information: entry into national phase

Ref document number: MX/A/2009/000126

Country of ref document: MX